rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jon Zinman

Director

Company insider

Files Form 4 as: Director, Keenova Therapeutics; Member of Strategy Committee, Azul.

In numbers

Trades disclosed
19
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
1
First trade
19 Feb 2024
Last trade
15 Jul 2026
Last filed
17 Jul 2026

Companies traded

Where they are an officer
AZUL AzulOfficer · Airlines & Air Freight · last 15 Jun 20260 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Keenova TherapeuticsDirector · last 15 Jul 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
15 Jul 2026filed 17 Jul 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code A—4,406 at $0.00filing
15 Jul 2026filed 17 Jul 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code A—4,406 at $0.00filing
15 Jun 2026filed 17 Jun 2026AZUL AzulAirlines & Air FreightSEC FORM 4 Code A—980,860 at $0.00filing
15 Jun 2026filed 17 Jun 2026AZUL AzulAirlines & Air FreightSEC FORM 4 Code A—980,860 at $0.00filing
2 Jun 2026filed 4 Jun 2026Keenova TherapeuticsSEC FORM 4 Code M—4,882filing
2 Jun 2026filed 4 Jun 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code M—4,882 at $0.00filing
2 Jun 2026filed 4 Jun 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code M—4,882 at $0.00filing
2 Jun 2026filed 4 Jun 2026Keenova TherapeuticsSEC FORM 4 Code M—4,882filing
23 Feb 2026filed 25 Feb 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code A—3,984 at $0.00filing
23 Feb 2026filed 25 Feb 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code A—3,984 at $0.00filing
1 Jan 2026filed 5 Jan 2026Keenova TherapeuticsSEC FORM 4 Code M—4,384filing
1 Jan 2026filed 5 Jan 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code M—4,384 at $0.00filing
1 Jan 2026filed 5 Jan 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code M—4,384 at $0.00filing
1 Jan 2026filed 5 Jan 2026Keenova TherapeuticsSEC FORM 4 Code M—4,384filing
14 Aug 2025filed 18 Aug 2025Mallinckrodtoption or derivativeSEC FORM 4 Code A—4,062 at $0.00filing
31 Jul 2025filed 4 Aug 2025Mallinckrodtoption or derivativeSEC FORM 4 Code A—21,886 at $0.00filing
1 Jan 2025filed 2 Jan 2025Mallinckrodtoption or derivativeSEC FORM 4 Code M—3,647 at $0.00filing
1 Jan 2025filed 2 Jan 2025MallinckrodtSEC FORM 4 Code M—3,647filing
19 Feb 2024filed 20 Feb 2024Mallinckrodtoption or derivativeSEC FORM 4 Code A—10,942 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

David NeelemanDirector · Director at Azul Sa, filing Form 4 there in the last year
John S. SlatteryMember of Strategic Committee · Member of Strategic Committee at Azul Sa, filing Form 4 there in the last year
Daniel TkaczChief Technical Officer · Chief Technical Officer at Azul Sa, filing Form 4 there in the last year
Abhi Manoj ShahChief Revenue Officer · Chief Revenue Officer at Azul Sa, filing Form 4 there in the last year
John Peter RodgersonCEO (see remarks) · CEO (see remarks) at Azul Sa, filing Form 4 there in the last year